Oxygenta Pharmaceutical Stock Hits New 52-Week Low at Rs. 58.4

Oxygenta Pharmaceutical has reached a significant milestone by hitting a new 52-week low of Rs. 58.4 on October 13, 2025. This marks a notable decline for the microcap company, which has seen its stock price fall by 16.21% over the past five days. The stock's performance today aligns with the broader sector trends, yet it continues to trade below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downward trajectory. Over the past year, Oxygenta Pharmaceutical has experienced a decline of 35.15%, significantly underperforming the market, which has seen a modest return of 1.08%. The company's financial health is concerning, with a negative book value and a high debt-to-equity ratio, suggesting challenges in long-term growth. Recent financial results have also been disappointing, with a substantial drop in profit before tax and net profit. Despite these challenges, there has been a rise in promoter confidence, as they have increased their stake in the company by 6.8% in the last quarter, now holding 57.92%. This development may reflect a belief in the company's potential amidst its current struggles.